D G Le Couteur

Author PubWeight™ 39.00‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Parkinson's disease, pesticides, and glutathione transferase polymorphisms. Lancet 1998 2.65
2 Physicians need to take the lead in deprescribing. Intern Med J 2015 2.04
3 The dopamine transporter gene and Parkinson's disease in a Chinese population. Neurology 1997 1.43
4 High-risk prescribing and incidence of frailty among older community-dwelling men. Clin Pharmacol Ther 2012 1.43
5 Lead poisoning from complementary and alternative medicine in multiple sclerosis. J Neurol Neurosurg Psychiatry 2000 1.42
6 Do medical courses adequately prepare interns for safe and effective prescribing in New South Wales public hospitals? Intern Med J 2009 1.20
7 Nephrotoxicity and hepatotoxicity of histamine H2 receptor antagonists. Drug Saf 2001 1.08
8 The Cys282Tyr polymorphism in the HFE gene in Australian Parkinson's disease patients. Neurosci Lett 2002 1.03
9 A randomized clinical trial of activated charcoal for the routine management of oral drug overdose. QJM 2005 0.98
10 Immunohistochemistry of omega class glutathione S-transferase in human tissues. J Histochem Cytochem 2001 0.92
11 The association between polymorphisms in the cytochrome P-450 2D6 gene and Parkinson's disease: a case-control study and meta-analysis. J Neurol Sci 1997 0.92
12 Variability in response to medicines in older people: phenotypic and genotypic factors. Clin Pharmacol Ther 2009 0.91
13 The effect of acute oxidative stress on the ultrastructure of the perfused rat liver. Pharmacol Toxicol 2001 0.90
14 Hydroxychloroquine overdose: toxicokinetics and management. J Toxicol Clin Toxicol 1999 0.90
15 Variations in the monoamine oxidase B (MAOB) gene are associated with Parkinson's disease. Mov Disord 1999 0.89
16 Alterations in liver sinusoidal endothelium in a baboon model of type 1 diabetes. Diabetologia 2007 0.87
17 31P and 1H NMR spectroscopic studies of liver extracts of carbon tetrachloride-treated rats. NMR Biomed 1999 0.86
18 Lifestyle factors, medications, and disease influence bone mineral density in older men: findings from the CHAMP study. Osteoporos Int 2010 0.86
19 Glutathione transferase Omega class polymorphisms in Parkinson disease. Neurology 2004 0.86
20 The C-caffeine breath test distinguishes significant fibrosis in chronic hepatitis B and reflects response to lamivudine therapy. Aliment Pharmacol Ther 2005 0.85
21 Cell membrane transport of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the liver and systemic bioavailability. Biochem Biophys Res Commun 2001 0.83
22 Toxicity of Passiflora incarnata L. J Toxicol Clin Toxicol 2000 0.83
23 The effect of aging on the immunohistochemistry of apolipoprotein E in the liver. Exp Gerontol 2004 0.82
24 Acute oxygen supplementation restores markers of hepatocyte energy status and hypoxia in cirrhotic rats. J Pharmacol Exp Ther 2000 0.81
25 Predictors of the rate of BMD loss in older men: findings from the CHAMP study. Osteoporos Int 2012 0.79
26 Vitamin D status among older community dwelling men living in a sunny country and associations with lifestyle factors: the Concord Health and Ageing in Men Project, Sydney, Australia. J Nutr Health Aging 2013 0.79
27 The ACE deletion polymorphism is not associated with Parkinson's disease. Eur Neurol 1999 0.79
28 Suicidal emperipolesis: a process leading to cell-in-cell structures, T cell clearance and immune homeostasis. Curr Mol Med 2015 0.78
29 Paraoxonase polymorphisms, pesticide exposure and Parkinson's disease in a Caucasian population. J Neural Transm (Vienna) 2000 0.78
30 Carbon monoxide wash-in method to determine gas transfer in vascular beds: application to rat hindlimb. Am J Physiol Heart Circ Physiol 2001 0.78
31 Hepatic disposition of neurotoxins and pesticides. Pharmacol Toxicol 2000 0.77
32 The monoamine oxidase B gene GT repeat polymorphism and Parkinson's disease in a Chinese population. J Neurol 2000 0.77
33 Focal necrotising vasculitis with secondary myositis following fluoxetine administration. Aust N Z J Med 1999 0.77
34 Effects of specific antibody Fab fragments on desipramine pharmacokinetics in the rat in vivo and in the isolated, perfused liver. J Pharmacol Exp Ther 1995 0.76
35 The serotonin transporter gene and Parkinson's disease. Eur Neurol 2000 0.76
36 Intrusive pain and worry about health in older men: the CHAMP study. Pain 2010 0.76
37 Intracerebral hemorrhage following possible interaction between celecoxib and clopidogrel. Ann Pharmacother 2001 0.75
38 Zeta class glutathione transferase polymorphisms and Parkinson's disease. J Neurol Neurosurg Psychiatry 2001 0.75
39 Ageing and reoxygenation injury in the liver. Scand J Gastroenterol 1999 0.75
40 Off-label use of medicines: time for action. Clin Pharmacol Ther 2012 0.75
41 P450 enzymes and Parkinson's disease. Mov Disord 1998 0.75
42 Hepatic artery flow change and hepatocyte oxygenation in human cirrhosis. Gastroenterology 1999 0.75
43 Silent myocardial ischaemia following methysergide overdose. Aust N Z J Med 2000 0.75
44 Poisoning by Amanita phalloides ("deathcap") mushrooms in the Australian Capital Territory. Med J Aust 1999 0.75
45 Delayed neuroleptic malignant syndrome following cessation of prolonged therapy with metoclopramide. Aust N Z J Med 1995 0.75
46 The medicolegal assessment: a risk factor for overdose? Med J Aust 2000 0.75
47 Asp or spa (snakebite or drowning)? Aust N Z J Med 1999 0.75
48 Deliberate self-poisoning with eucalyptus oil in an elderly woman. Aust N Z J Med 1998 0.75